Inventor · disambiguated record
Christopher Mohr
Also filed as: MOHR CHRISTOPHER · MOHR CHRISTOPHER P
4 granted patents·6 pending applications·5 citations·filing 2019–2025
67Inventor score
Files withAMGEN INC10
Top patents by PatentIndex Score
10 records- 0191US11891435B2Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereofAMGEN INC·Filed 2021·Granted Feb 6, 2024·1 cites·24 claims
- 0291US10738110B2PAC1 antibodies and uses thereofAMGEN INC·Filed 2019·Granted Aug 11, 2020·3 cites·17 claims
- 0385US11248043B2Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereofAMGEN INC·Filed 2020·Granted Feb 15, 2022·1 cites·33 claims
- 0481US2024150448A1Pac1 antibodies and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 0576US2025304599A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2024·Application pending·0 cites
- 0669US2025236631A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 0755US12384849B2Bispecific antibodies with cleavable C-terminal charge-paired tagsAMGEN INC·Filed 2019·Granted Aug 12, 2025·0 cites·13 claims
- 0854US2025059205A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 0950US2025197518A1Bispecific antibodies with cleavable c-terminal charge-paired tagsAMGEN INC·Filed 2025·Application pending·0 cites
- 1049US2022363770A1Anti-cgrp receptor/anti-pac1 receptor bispecific antigen binding proteinsAMGEN INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Mohr files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →